lomexin 2 %
recordati industria chimica e farmaceutica s.p.a., taliansko - fentikonazol - 54 - gynaecologica
lomexin 600 mg
recordati industria chimica e farmaceutica s.p.a., taliansko - fentikonazol - 54 - gynaecologica
medocriptine
medochemie ltd., cyprus - bromokriptín - 54 - gynaecologica
advantan mastný krém
leo pharma a/s , dánsko - metylprednizolónaceponát - 46 - dermatologica
oxid dusný medicinálny air products 100 % v/v plyn na inhaláciu
air products slovakia s r.o., slovensko - oxid dusný - 05 - anaesthetica (celkovÉ)
midazolam kalceks 5 mg/ml injekčný/infúzny roztok
as kalceks, lotyšsko - midazolam - 57 - hypnotica, sedativa
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hypofÝzy a hypotalamickÝch hormÓny a ich analÓgy - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
midazolam kalceks 1 mg/ml injekčný/infúzny roztok
as kalceks, lotyšsko - midazolam - 57 - hypnotica, sedativa
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate disodný, glycopyrronium bromid - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
riarify (previously chf 5993 chiesi farmaceutici s.p.a.)
chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - udržiavacia liečba u dospelých pacientov so stredne závažnou až závažnou chronickou obštrukčnou chorobou pľúc (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačného kortikosteroidu a dlhodobo pôsobiaci beta2-agonista (pre ovplyvnenie príznakov a prevencie exacerbácií pozri časť 5.